Navigation Links
Thermage Schedules Shareholder Meeting for Vote on the Issuance of Common Stock in Connection With the Reliant Acquisition
Date:11/24/2008

HAYWARD, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM) today announced that its S-4 Registration Statement, filed with the Securities and Exchange Commission regarding its proposed acquisition of Reliant, Inc., has been declared effective. The proxy will be mailed beginning on or about November 25, 2008 to shareholders of record as of October 31, 2008. The Company has set a date of Tuesday, December 23 for a meeting of its shareholders to vote on the issuance of common stock in connection with the proposed acquisition. The meeting will be held at Thermage's corporate offices at 25881 Industrial Boulevard, Hayward, California 94545 at 9:00 a.m. PST.

"Scheduling the shareholder meeting was a significant step, and we are very happy to be moving forward to complete this transaction, which we believe offers many benefits to our customers and shareholders," said Stephen J. Fanning, Chairman of the Board, President and CEO of Thermage. "The proposed transaction combines two well-recognized and respected brands in the aesthetics device industry. Both Thermage and Reliant are known for their innovation and our combination will offer opportunities for an expanded market presence through the cross-selling of our products. Both of our business models generate substantial recurring revenue. Finally, we have identified significant cost savings that should enhance the efficiency of our operations. We are very excited about this transaction and, pending shareholder approval, are on-track to close by year-end."

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.

Additional Information and Where You Can Find It

This communication may be deemed to be solicitation material in respect of the proposed transaction between Thermage and Reliant. In connection with the transaction, Thermage has filed a registration statement on Form S-4 with the SEC containing a proxy statement/prospectus/ information statement. The proxy statement/prospectus/information statement will be mailed to the stockholders of Thermage and Reliant. Investors and security holders of Thermage and Reliant are urged to read the proxy statement/prospectus/information statement when it becomes available because it will contain important information about Thermage, Reliant and the proposed transaction. The proxy statement/prospectus/information statement (when it becomes available), and any other documents filed by Thermage with the SEC, may be obtained free of charge at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Thermage by contacting Thermage Investor Relations by e-mail at IR@thermage.com or by telephone at (510) 259-7117. Investors and security holders are urged to read the proxy statement/prospectus/information statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliants Results
2. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
3. Thermage, Inc. to Present at the Maxim Group Growth Conference
4. Thermage Announces Second Quarter 2008 Financial Results
5. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
6. Thermage and Reliant Technologies to Join Forces
7. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
8. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
9. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
10. Thermage, Inc. Announces Initial Shipments of Cellulite Product
11. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... 43rd President of the United States of America: George W. Bush , ... the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh ...
(Date:3/23/2017)... ... , ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon ... talked on her program about how she is looking forward to World Water Day ... important distinction. World Water Day, Kleyne pointed out, is an occasion for looking ahead ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... that help improve all aspects of people’s health and nutrition, announced its product ... products. , Natural Subsistence develops nutritional supplements that help people improve all ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics ... serious so build on a solid foundation. As experts in dangerous situations the ... that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
Breaking Medicine Technology: